Mirum Pharmaceuticals, Inc. (MIRM)
99.38
+5.38
(+5.72%)
USD |
NASDAQ |
Jun 11, 16:00
99.00
-0.38
(-0.38%)
After-Hours: 20:00
Mirum Pharmaceuticals Accounts Payable (Quarterly) : 59.40M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 59.40M |
| December 31, 2025 | 9.614M |
| September 30, 2025 | 12.17M |
| June 30, 2025 | 17.66M |
| March 31, 2025 | 11.64M |
| December 31, 2024 | 14.62M |
| September 30, 2024 | 9.545M |
| June 30, 2024 | 9.842M |
| March 31, 2024 | 15.98M |
| December 31, 2023 | 7.416M |
| September 30, 2023 | 7.369M |
| June 30, 2023 | 14.45M |
| March 31, 2023 | 6.44M |
| December 31, 2022 | 8.69M |
| September 30, 2022 | 10.55M |
| Date | Value |
|---|---|
| June 30, 2022 | 8.119M |
| March 31, 2022 | 4.943M |
| December 31, 2021 | 9.166M |
| September 30, 2021 | 5.003M |
| June 30, 2021 | 5.38M |
| March 31, 2021 | 5.658M |
| December 31, 2020 | 3.151M |
| September 30, 2020 | 5.177M |
| June 30, 2020 | 3.024M |
| March 31, 2020 | 3.265M |
| December 31, 2019 | 3.351M |
| September 30, 2019 | 2.665M |
| June 30, 2019 | 2.348M |
| March 31, 2019 | 2.375M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 395.47M |
| Incyte Corp. | 228.62M |
| Ionis Pharmaceuticals, Inc. | 26.03M |
| Travere Therapeutics, Inc. | 12.91M |
| Vertex Pharmaceuticals, Inc. | 489.30M |